Serotonin Uptake InhibitorsSerotoninCitalopramFluoxetineParoxetineFluvoxamineSerotonin Plasma Membrane Transport ProteinsAntidepressive Agents, Second-GenerationAntidepressive Agents, TricyclicAntidepressive AgentsSertralineReceptors, SerotoninReceptor, Serotonin, 5-HT1ASerotonin SyndromeReceptor, Serotonin, 5-HT2ASerotonin AntagonistsSerotonin Receptor AgonistsReceptors, Serotonin, 5-HT1CyclohexanolsReceptor, Serotonin, 5-HT2CSerotonin 5-HT2 Receptor AntagonistsReceptor, Serotonin, 5-HT1BSerotonin AgentsReceptors, Serotonin, 5-HT2Depressive DisorderReceptor, Serotonin, 5-HT2BSerotonin 5-HT1 Receptor AntagonistsSerotonin 5-HT2 Receptor AgonistsDepressive Disorder, MajorSerotonergic NeuronsSerotonin 5-HT1 Receptor AgonistsTryptophan Hydroxylase8-Hydroxy-2-(di-n-propylamino)tetralinDepressionAdrenergic Uptake InhibitorsRaphe NucleiLofepramineReceptors, Serotonin, 5-HT31-NaphthylamineDothiepinDesipramineKetanserinHydroxyindoleacetic Acid5-HydroxytryptophanReceptors, Serotonin, 5-HT45,7-DihydroxytryptamineAnti-Anxiety AgentsBehavior, AnimalObsessive-Compulsive DisorderDrug InteractionsSerotonin 5-HT4 Receptor AgonistsFenfluramineMonoamine Oxidase InhibitorsToxicity Tests, SubacuteClomipramineDose-Response Relationship, DrugMoclobemideDepressive Disorder, Treatment-ResistantMianserinNorepinephrine Plasma Membrane Transport ProteinsSuicidePremenstrual SyndromeImipramineAutoreceptorsAnxiety DisordersPiperazinesPsychiatric Status Rating ScalesCognitive TherapyAnxietyMicrodialysisDouble-Blind MethodRats, Sprague-DawleyBrainSwimmingTreatment OutcomeSexual Dysfunction, PhysiologicalBuspironeHysterotomyPregnancy ComplicationsMembrane Transport ProteinsPanic DisorderAntipsychotic AgentsPsychotropic DrugsNortriptylineAnalysis of VarianceCyclopropanesDroxidopaImmobility Response, TonicCytochrome P-450 CYP2D6AmitriptylineMethysergideFenclonineMotor ActivityPsychotherapyNeurotransmitter Uptake InhibitorsRandomized Controlled Trials as TopicDopaminePatient DropoutsTime FactorsDrug Utilization Review